An off-the-shelf MSC product derived from lab-scale autologous process
Drawing on their scientific and medical expertise in the field of autologous MSCs, local researchers, professors and clinicians wanted to offer patients suffering from various autoimmune diseases an affordable and safe treatment.
Our Approach
In just 30 months, our dedicated teams have accomplished a significant milestone: the successful development, manufacturing, and validation of clinical-grade adipose-derived Mesenchymal Stem Cells (MSCs) based on a large-scale allogeneic process. These cells have received authorization from the French National Agency for Medicinal Products (ANSM) and are being injected in a range of Human clinical studies.
Results and outcome
Study model for Research Programs
Drug Product in various Clinical Trials
Starting material for the generation of GMP exosomes
Cargo for various molecules and viruses
Let’s talk about your project
Let’s turn your vision into a reality.
Phone: +33 534 276 550
Address: Cell-Easy SAS, 4 bis avenue Hubert Curien,
31100 Toulouse, France
Mail: info@cell-easy.com
